Dr. McIntyre has more than 25 years of experience in the drug discovery and development industry. She has authored more than 30 regulatory submissions and is a board-certified toxicologist with extensive experience in moving compounds through lead optimization and clinical development onto the market. Her experience covers multiple therapeutic areas including oncology (recently immune-oncology), infectious diseases, central nervous system and metabolic/endocrine as well as various therapies including small drugs, treatment vaccines, immunomodulators, antibodies, immunoconjugates and peptide mimetics. Dr. McIntyre is also board certified in Clinical Pathology (hematology and clinical chemistry) by the American Society of Clinical Pathology. She held the position of Senior Vice President of Research at Furiex Pharmaceuticals, Inc. from April 1, 2010 until December 2015 and she served as head of Pharmaceutical Product Development LLC’s compound partnering business for 12 years prior to that. Dr. McIntyre received her B.A. in Biology from Merrimack College. She earned MS and PhD degrees in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill.
Gail McIntyre, PhD, DABT
Senior Vice President, Research & Development